MCG Programme Team
Over 200 people have been involved in the programme, including cancer doctors, geneticists, nurses, genetic counsellors, patients, patient representative groups and cancer charities. The following are some of the key people driving the programme.
Professor Nazneen Rahman is the MCG programme director.
The Division of Genetics and Epidemiology at Institute of Cancer Research, the Cancer Genetics Unit, the Gynaecological Cancer Unit and the Breast Unit at the Royal Marsden Hospital, The NIHR Biomedical Research Centre and the TGLclinical laboratory have been centrally involved in developing and validating the MCG outputs.
MCG Programme Advisory Board
Michael R Stratton (chair), Wellcome Trust Sanger Institute
Mark Bale, Department of Health
John Bell, University of Oxford
Hilary Burton, PHG Foundation
Peter Donnelly, The Wellcome Trust Centre for Human Genetics
Peter Farndon, National Education and Genetics Centre/University of Birmingham
Nic Jones, Cancer Research UK
Stan B Kaye, Royal Marsden NHS Foundation Trust
Alistair Kent, Genetic Alliance
MCG Programme Partners
Many different groups have been engaged with and supportive of the programme. The following have been particularly involved.